MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 38 filers reported holding MILESTONE PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,994 | +8.8% | 21,611 | 0.0% | 0.00% | – |
| Q2 2023 | $61,591 | -28.9% | 21,611 | -1.8% | 0.00% | – |
| Q1 2023 | $86,676 | -50.5% | 21,999 | -50.2% | 0.00% | – |
| Q4 2022 | $174,976 | -13.4% | 44,186 | +100.9% | 0.00% | – |
| Q3 2022 | $202,000 | +57.8% | 21,996 | +1.8% | 0.00% | – |
| Q2 2022 | $128,000 | -8.6% | 21,608 | -0.9% | 0.00% | – |
| Q1 2022 | $140,000 | +2.9% | 21,802 | +4.7% | 0.00% | – |
| Q4 2021 | $136,000 | +16.2% | 20,832 | +1.9% | 0.00% | – |
| Q3 2021 | $117,000 | +28.6% | 20,448 | +23.0% | 0.00% | – |
| Q2 2021 | $91,000 | -8.1% | 16,626 | -2.3% | 0.00% | – |
| Q1 2021 | $99,000 | -13.2% | 17,016 | 0.0% | 0.00% | – |
| Q4 2020 | $114,000 | -11.6% | 17,016 | -3.1% | 0.00% | – |
| Q3 2020 | $129,000 | – | 17,562 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alta Fundamental Advisers LLC | 1,176,189 | $3,646,186 | 1.74% |
| Bleichroeder LP | 1,326,085 | $4,110,864 | 1.01% |
| BML Capital Management, LLC | 272,500 | $844,750 | 0.78% |
| VR Adviser, LLC | 2,208,812 | $6,847,317 | 0.72% |
| Lion Point Capital, LP | 450,207 | $1,395,642 | 0.62% |
| PVG ASSET MANAGEMENT CORP | 15,405 | $47,755 | 0.32% |
| Affinity Asset Advisors, LLC | 335,068 | $1,038,711 | 0.29% |
| RTW INVESTMENTS, LP | 3,256,102 | $10,093,916 | 0.21% |
| Ikarian Capital, LLC | 462,828 | $1,434,767 | 0.17% |
| Boxer Capital, LLC | 309,007 | $957,922 | 0.05% |